Dennis A Reddig Od & Michael D. Red Medicare Supplier Location: 32 Hummer Rd, Ephrata, Pennsylvania 17522 Phone: (717) 733-0148 |
Giant Pharmacy #6501 Durable Medical Equipment & Medical Supplies Location: 850e Main St, Ephrata, Pennsylvania 17522 Phone: (717) 733-6335 |
Wellspan Medical Equipment Durable Medical Equipment & Medical Supplies Location: 1081 Sharp Ave, Ephrata, Pennsylvania 17522 Phone: (717) 733-0405 |
Cvs Pharmacy #05721 Durable Medical Equipment & Medical Supplies Location: 440 N Reading Rd, Ephrata, Pennsylvania 17522 Phone: (717) 733-1818 |
Persila V Mertz Md Pc Medicare Supplier Location: 115 E Main St, Ephrata, Pennsylvania 17522 Phone: (717) 733-3600 |
Walmart Pharmacy 10-2340 Durable Medical Equipment & Medical Supplies Location: 890 E Main St, Ephrata, Pennsylvania 17522 Phone: (717) 721-6690 |
Weis Pharmacy #79 Pharmacy Location: 331 N Reading Rd, Ephrata, Pennsylvania 17522 Phone: (717) 733-4052 |
News Archive
A family of small RNA molecules affects the development of cells that give rise to the placenta - an organ that transfers oxygen and nutrients from mother to fetus - in ways that could contribute to a serious pregnancy complication, UT Southwestern Medical Center researchers report.
iCo Therapeutics, today announced that all nominees listed in the management information circular dated June 1, 2015 were elected as directors at its 2015 Annual Meeting of Shareholders, held earlier today, June 26 2015.
Light Sciences Oncology, Inc. (LSO) today announced the treatment of the first patients in a Phase 2 clinical trial of its innovative targeted drug treatment Aptocine(TM) (talaporfin sodium) in Benign Prostatic Hyperplasia (BPH). The Phase 2 trial expands the Aptocine BPH development program on the basis of a Phase 1 study at escalating light doses. In the open-label Phase 2 trial, Aptocine is being tested for safety and efficacy in 40 patients with lower urinary tract symptoms (LUTS) due to BPH. Aptocine is also in two Phase 3 clinical trials for solid tumors in the liver as well as preclinical development for prostate cancer.
A new computer model that uses machine learning and de-identified and aggregated search and location data from logged-in Google users was significantly more accurate in identifying potentially unsafe restaurants when compared with existing methods of consumer complaints and routine inspections, according to new research led by Google and Harvard T.H. Chan School of Public Health.
› Verified 1 days ago